16 Jun 2025
In a Q&A for Applied Clinical Trials, Megan Bailey, Executive Vice President and President of Central Laboratories & International at Labcorp, discusses how central labs are evolving into strategic partners for decentralized and hybrid clinical trials. She highlights Labcorp’s investment in advanced technologies—end-to-end tracking, automation, AI integration—and global logistics systems that ensure sample integrity and streamline operations across diverse geographies. Bailey emphasizes that central labs now play a pivotal role in unifying data flow, breaking operational silos, and prioritizing patient centric, data integrated trial execution. Read the full article on Applied Clinical Trials to discover how Labcorp is shaping the future of clinical research.